ADiTx Therapeutics(纳斯达克股票代码:ADTX)宣布,其1股合并为27股的反向股票拆分计划,将于2026年5月18日市场开盘交易时正式生效。
此项举措将显著提升公司每股股票的交易价格。反向拆股完成后,公司已发行普通股的数量将按比例大幅减少,而股东所持股票的总价值在理论上将保持不变。公司此举通常旨在满足交易所的最低股价要求,或提升其在投资者眼中的形象。
ADiTx Therapeutics(纳斯达克股票代码:ADTX)宣布,其1股合并为27股的反向股票拆分计划,将于2026年5月18日市场开盘交易时正式生效。
此项举措将显著提升公司每股股票的交易价格。反向拆股完成后,公司已发行普通股的数量将按比例大幅减少,而股东所持股票的总价值在理论上将保持不变。公司此举通常旨在满足交易所的最低股价要求,或提升其在投资者眼中的形象。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.